Neha Bhatia

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (8)

• Gaussian-based 3D-QSAR and Pharmacophore Mapping Studies of Indole Derivatives as Aromatase Inhibitors
  Anti-Cancer Agents in Medicinal Chemistry 2026 DOI: 10.2174/0118715206390949250805064957
  +Save
• Protacs Targeting ERα in the Effective Management of Endocrinal Resistance Breast Cancer
  Archiv der Pharmazie 2025 DOI: 10.1002/ardp.70176
  +Save
• Optimizing selective estrogen receptor degraders for anticancer drug development
  Future Medicinal Chemistry 2025 DOI: 10.1080/17568919.2025.2467615
  +Save
• Simulation, 3D-QSAR, molecular docking and pharmacophore mapping studies on indole derivatives as aromatase inhibitors
  Letters in Drug Design & Discovery 2025 DOI: 10.1016/j.lddd.2025.100007
  +Save
• Medicinal Aspects of PTP1B Inhibitors as Anti-Breast Cancer Agents: An Overview
  Current Medicinal Chemistry 2024 DOI: 10.2174/0929867331666230914103645
  +Save
• Molecular docking, 3D-QSAR and simulation studies for identifying pharmacophoric features of indole derivatives as 17β-hydroxysteroid dehydrogenase type 5 (17β-HSD5) inhibitors
  Journal of Biomolecular Structure and Dynamics 2023 DOI: 10.1080/07391102.2023.2175265
  +Save
• Recent Advancements in the Discovery of MDM2/MDM2-p53 Interaction Inhibitors for the Treatment of Cancer
  Current Medicinal Chemistry 2023 DOI: 10.2174/0929867330666221114103924
  +Save
• Elacestrant: a new FDA-approved SERD for the treatment of breast cancer
  Medical Oncology 2023 DOI: 10.1007/s12032-023-02045-2
  +Save